ESC Premium Access

Identifying patients with atrial fibrillation and "truly low" thromboembolic risk who are poorly characterized by CHA2DS2-VASc: Superior performance of a novel machine learning tool in GARFIELD-AF

Congress Presentation

About the speaker

Professor Keith Fox

University of Edinburgh, Edinburgh (United Kingdom of Great Britain & Northern Ireland)
45 presentations
1 follower

5 more presentations in this session

A nationwide register study to compare bleeding rates in patients with non-valvular atrial fibrillation prescribed oral anticoagulants

Speaker: Professor S. Halvorsen (Oslo, NO)


ESC-EURObservational Research Programme: In-hospital and 1-year follow-up of the Long-term Atrial Fibrillation Ablation Registry, Conducted by the European Heart Rhythm Association

Speaker: Associate Professor E. Arbelo (Barcelona, ES)


XAPASS: Evidence of Safety and Effectiveness in Japanese Patients Treated with Rivaroxaban for Stroke Prevention in Atrial Fibrillation under Real-World Clinical Practice

Speaker: Professor T. Ikeda (Tokyo, JP)


Association of Inappropriate Dosing of Non-Vitamin K Oral Anticoagulants and Risk of Adverse Events: Results from the ORBIT-AF II Registry

Speaker: Professor J. Piccini (Durham, US)


A Large-Scale Multi-Center Registry of Patients Undergoing Radiofrequency Catheter Ablation for Atrial Fibrillation: Kansai Plus Atrial Fibrillation Study

Speaker: Doctor S. Shizuta (Kyoto, JP)


Access the full session

Registries atrial fibrillation

Speakers: Professor K. Fox, Professor S. Halvorsen, Associate Professor E. Arbelo, Professor T. Ikeda, Professor J. Piccini...

About the event


ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb